Antisense oligonucleotide not checked

Novartis · NIO752

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
3 active
4 in total · 2 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“A single intrathecal (cerebrospinal) injection of NIO752 of Dose A”In the company’s words, NCT05469360 on ClinicalTrials.gov
Tested for
Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS), Progressive Supranuclear Palsy, Corticobasal Degeneration, Frontotemporal Lobar Degeneration, Tauopathies, Alzheimer Disease, Mild Cognitive Impairment
Main trialPhase 3
“This Phase III study is intended to evaluate the efficacy and safety of NIO752 in participants with Progressive Supranuclear Palsy (PSP). Eligible participants will be randomized to receive either NIO752 or placebo followed by an open-label extension.”In the company’s words, NCT07498426 on ClinicalTrials.gov
Other names
NIO752

Other drugs for Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)

All 3 drugs for Progressive Supranuclear Palsy Richardson Syndrome (PSP-RS)

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 3Recruiting 20 Jul 2029 A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
Phase 2Not yet recruiting 26 Mar 2029 A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of NIO752 in Primary Tauopathies
Phase 1Active, not recruiting 30 Jul 2026 Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants
Phase 1Completed 17 Oct 2024 Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Antisense oligonucleotide

Following is part of Solo: you see every change to Antisense oligonucleotide the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in